Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis

Jing Zhang; Jiaming Liu; Chenjing Zhu; Jialing He; Jinna Chen; Yunliu Liang; Feng Yang; Xin Wu; Xuelei Ma

doi:10.18632/oncotarget.15044

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis

Jing Zhang _, Jiaming Liu, Chenjing Zhu, Jialing He, Jinna Chen, Yunliu Liang, Feng Yang, Xin Wu and Xuelei Ma

PDF | HTML | How to cite

Oncotarget. 2017; 8:24797-24803. https://doi.org/10.18632/oncotarget.15044

Metrics: PDF 2092 views | HTML 2361 views | ?

Abstract

Jing Zhang1,2,*, Jiaming Liu1,3,*, Chenjing Zhu1,*, Jialing He1, Jinna Chen1, Yunliu Liang1, Feng Yang1, Xin Wu1, Xuelei Ma1,*

1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, PR China

2Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, PR China

3Department of Urology, Institute of Urology, Laboratory of Reconstructive Urology, West China Hospital, Sichuan University, Chengdu 610041, PR China

*These authors have contributed equally to this work

Correspondence to:

Xuelei Ma, email: [email protected]

Keywords: VEGF, cervical cancer, prognosis

Received: October 31, 2016 Accepted: January 04, 2017 Published: February 03, 2017

ABSTRACT

The prognostic role of vascular endothelial growth factor (VEGF) in cervical cancer is controversial to date. The aim of this study was to evaluate the prognostic value of VEGF and VEGF-C in patients with cervical cancer. Relevant studies were identified by systematic search of the PubMed and Embase database. The primary data of eligible studies was hazard ratio (HR) with 95% confidence interval (95% CI) of survival outcomes, including overall survival (OS), disease-free survival (DFS) and progression-free survival (PFS). Pooled HR (95% CI) was calculated to evaluate the prognostic role of VEGF and VEGF-C in cervical cancer patients. The methodological qualities of the included studies were assessed using REMARK. Fourteen eligible articles including 1306 patients were included in the meta-analysis. The pooled HRs (95% CIs) of VEGF for OS and DFS/PFS were 2.29 [1.27, 4.14] and 2.77 [1.37, 5.62], respectively. The HR (95% CI) of VEGF-C for OS was 3.94 [2.22, 6.99]. This meta-analysis suggested that high expressions of VEGF and VEGF-C were significantly associated with poor survival outcome in cervical cancer patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15044

Publication Alerts

Research Papers:

Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis

Abstract